List of Solodyn drug patents

Solodyn is owned by Bausch.

Solodyn contains Minocycline Hydrochloride.

Solodyn has a total of 8 drug patents out of which 0 drug patents have expired.

Solodyn was authorised for market use on 08 May, 2006.

Solodyn is available in tablet, extended release;oral dosage forms.

Solodyn can be used as treatment of inflammatory lesions of non-nodular moderate to severe acne vulgaris, treatment of acne.

The generics of Solodyn are possible to be released after 17 November, 2031.

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8722650 BAUSCH Extended-release minocycline dosage forms
Jun, 2025

(2 years from now)

US8252776 BAUSCH Minocycline oral dosage forms for the treatment of acne
Jun, 2025

(2 years from now)

US8268804 BAUSCH Minocycline oral dosage forms for the treatment of acne
Jun, 2025

(2 years from now)

US7790705 BAUSCH Minocycline oral dosage forms for the treatment of acne
Jun, 2025

(2 years from now)

US7919483 BAUSCH Method for the treatment of acne
Mar, 2027

(4 years from now)

US7544373 BAUSCH Minocycline oral dosage forms for the treatment of acne
Apr, 2027

(4 years from now)

US7541347 BAUSCH Minocycline oral dosage forms for the treatment of acne
Apr, 2027

(4 years from now)

US9192615 BAUSCH Method for the treatment of acne and certain dosage forms thereof
Nov, 2031

(8 years from now)

Drugs and Companies using MINOCYCLINE HYDROCHLORIDE ingredient

Market Authorisation Date: 08 May, 2006

Treatment: Treatment of acne; Treatment of inflammatory lesions of non-nodular moderate to severe acne vulgaris

Dosage: TABLET, EXTENDED RELEASE;ORAL

How can I launch a generic of SOLODYN before it's patent expiration?
More Information on Dosage

SOLODYN family patents

23

United States

2

Japan

1

South Africa

1

Australia

1

Norway

1

New Zealand

1

Canada

1

China

1

European Union

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic